Development of a risk scoring system for evaluating the prognosis of patients with Her2-positive breast cancer.

Cancer Cell Int · 2020 · PMC7161270 · PMID 32322168

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Our study found that SCUBE3 also showed a trend of overexpression in Her2-positive breast cancer, and the related mechanism of its participation in this progression needs to be further explored.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.